Company / Current Assets
Exelixis Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.4B
FY2025
5-year range
$1.3B / $1.8B
FY2021-FY2025
Trend
-1.7%
vs FY2024
Sector context
#39 of 213
Health Care
What the data says
Exelixis's current assets of $1.4B is higher than 82% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 10 years, ranging from $469M in FY2016 to $1.8B in FY2021.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of -0.0%. Top quartile in the Health Care sector.
Improved from $1.3B to $1.4B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -3.8%
- 5-Year CAGR
- -0.0%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 213This company $1.4B Sector average $2.5B
▼
-42.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.0%, indicating a declining trend.
- In FY2025, current assets decreased 1.7% year-over-year.
- Ranks #39 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | -1.7% |
| FY2024 | $1.5B | +11.4% |
| FY2023 | $1.3B | -18.6% |
| FY2022 | $1.6B | -11.8% |
| FY2021 | $1.8B | +26.9% |
| FY2020 | $1.4B | +42.9% |
| FY2019 | $1.0B | +12.7% |
| FY2018 | $897.0M | +85.0% |
| FY2017 | $484.9M | +3.4% |
| FY2016 | $469.0M | +162.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026